Reply to: "Ammonia and prognosis of cirrhosis: A new perspective for identifying high risk patients"

Affiliations

• ¹ Institute of Liver Studies, Dept of Inflammation Biology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King´s College London, London, United Kingdom.
• ² Digestive Disease Department, Hospital Clínico Universitario de Valencia, Spain; INCLIVA Biomedical Research Institute, Valencia, Spain.
• ³ INCLIVA Biomedical Research Institute, Valencia, Spain.
• ⁴ Liver Failure Group, Institute for Liver and Digestive Health, University College London, Royal Free Campus, United Kingdom; European Foundation for the Study of Chronic Liver Failure (EF Clif), Spain. Electronic address: r.jalan@ucl.ac.uk.